Sevoflurane inhibition of the slowly activating delayed rectifier K + current in guinea pig ventricular cells

Journal of Pharmacological Sciences

Volumn 95, Issue 3, 2004, Pages 363-373

  Shibata, Shigehiro ^a   Ono, Kyoichi ^b   Iijima, Toshihiko ^b  

^a AKITA CITY HOSPITAL   (Japan)

^b AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Chromanol 293B; Delayed rectifier K+ current; E4031; QT prolongation; Sevoflurane

Indexed keywords

1 [2 (6 METHYL 2 PYRIDYL)ETHYL] 4 (4 METHYLSULFONYLAMINOBENZOYL)PIPERIDINE; CHROMANOL 293B; HALOTHANE; POTASSIUM CHANNEL BLOCKING AGENT; SEVOFLURANE;

ACTION POTENTIAL DURATION; ACTIVATION KINETICS; ANIMAL CELL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DELAYED RECTIFIER POTASSIUM CURRENT; DRUG EFFECT; GUINEA PIG; HEART MUSCLE CELL; HEART MUSCLE POTENTIAL; HEART REPOLARIZATION; HEART VENTRICLE; HEART VENTRICLE REPOLARIZATION; IC 50; KINETICS; NONHUMAN; PATCH CLAMP; POTASSIUM CONDUCTANCE; POTASSIUM CURRENT; QT PROLONGATION; RAPIDLY ACTIVATING DELAYED RECTIFIER POTASSIUM CURRENT; SLOWLY ACTIVATING DELAYED RECTIFIER POTASSIUM CURRENT;

EID: 3843148331     PISSN: 13478613     EISSN: None     Source Type: Journal    
DOI: 10.1254/jphs.FP0040024     Document Type: Article

References (42)

1. + currents. J Gen Physiol. 1990;347:641-657.
2. Chiang CE, Roden DM. The long QT syndromes: genetic basis and clinical implications. J Am Coll Cardiol. 2000;36:1-12.
3. Schmeling WT, Warltier DC, McDonald DJ, Madsen KE, Atlee JL, Kampine JP. Prolongation of the QT interval by enflurane, isoflurane, and halothane in humans. Anesth Analg. 1991;72: 137-144.
4. Gallagher JD, Weindling SN, Anderson G, Fillinger MP. Effects of sevoflurane on QT interval in a patient with congenital long QT syndrome. Anesthesiology. 1998;89:1569-1573.
5. Kuenszberg E, Loeckinger A, Kleinsasser A, Lindner KH, Puehringer F, Hoermann C. Sevoflurane progressively prolongs the QT interval in unpremedicated female adults. Eur J Anaesthesiol. 2000;17:662-664.
6. Kleinsasser A, Loeckinger A, Lindner KH, Keller C, Boehler M, Puehringer F. Reversing sevoflurane-associated Q-Tc prolongation by changing to propofol. Anaesthesia. 2001;56:248-250.
7. Paventi S, Santevecchi A, Ranieri R. Effects of sevoflurane versus propofol on QT interval. Minerva Anestesiol. 2001;67: 637-640.
8. + current by halothane in single frog atrial cells. Eur J Pharmacol. 1986;126:293-295.
9. Hirota K, Ito Y, Momose Y. Effects of halothane on membrane potentials and membrane ionic currents in single bullfrog atrial cells. Acta Anaesthesiol Scand. 1988;32:333-338.
10. Hirota K, Ito Y, Masuda A, Momose Y. Effects of halothane on membrane ionic currents in guinea pig atrial and ventricular myocytes. Acta Anaesthesiol Scand. 1989;33:239-244.
11. Park WK, Pancrazio JJ, Suh CK, Lynch C III. Myocardial depressant effects of sevoflurane. Mechanical and electrophysiologic actions in vitro. Anesthesiology. 1996;84:1166-1176.
12. Chen X, Yamakage M, Yamada Y, Tohse N, Namiki A. Inhibitory effects of volatile anesthetics on currents produced on heterologous expression of KvLQT1 and minK in Xenopus oocytes. Vasc Pharmacol. 2002;39:33-38.
13. Li J, Correa AM. Kinetic modulation of HERG potassium channels by the volatile anesthetic halothane. Anesthesiology. 2002;97:921-930.
14. Yap YG, Camm AJ. Drug induced QT prolongation and torsades de pointes. Heart. 2003;89:1363-1372.
15. sK channels by the chromanol 293B. Pflugers Arch. 1996;432:1094-1096.
16. + current by chromanol 293B in guinea-pig ventricular cells. Br J Pharmacol. 2000;129:1007-1013.
17. Ks in guinea-pig isolated ventricular myocytes. Exp Physiol. 1996;81:587-603.
18. Hamill OP, Marty A, Neher E, Sakmann B, Sigworth FJ. Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflugers Arch. 1981;391:85-100.
19. Lin LH, Chen LL, Zirrolli JA, Harris RA. General anesthetics potentiate gamma-aminobutyric acid actions on gamma-aminobutyric acid A receptors expressed by Xenopus oocytes: lack of involvement of intracellular calcium. J Pharmacol Exp Ther. 1992;263:569-578.
20. + currents. Pflugers Arch. 1992;420:180-186.
21. Evers AS, Crowder CM. General Anesthesia. In: Hardman JG, Limbird, Gilman AG, editors. Goodman & Gilman's the pharmacological basis of therapeutics. 10th ed. McGraw-Hill; 2001. p. 337-365.
22. Chiang CE, Roden DM. The long QT syndromes: genetic basis and clinical implications. J Am Coll Cardiol. 2000;36:1-12.
23. Franks NP, Lieb WR. Molecular and cellular mechanisms of general anaesthesia. Nature. 1994;367:607-614.
24. Zorn L, Kulkarni R, Anantharam V, Bayley H, Treistman SN. Halothane acts on many potassium channels, including a minimal potassium channel. Neurosci Lett. 1993;161:81-84.
25. Walsh KB, Kass RS. Regulation of a heart potassium channel by protein kinase A and C. Science. 1988;242:67-69.
26. Miller KW. The nature of sites of general anaesthetic action. Br J Anaesth. 2002;89:17-31.
27. Rebecchi MJ, Pentyala SN. Anaesthetic actions on other targets: protein kinase C and guanine nucleotide-binding proteins. Br J Anaesth. 2002;89:62-78.
28. Richards CD. Anaesthetic modulation of synaptic transmission in the mammalian CNS. Br J Anaesth. 2002;89:79-90.
29. Trudell JR, Bertaccini E. Molecular modelling of specific and non-specific anaesthetic interactions. Br J Anaesth. 2002;89:32-40.
30. + channels. Nat Neurosci. 1999;2:422-426.
31. + channels. Curr Drug Targets. 2003;4:347-351.
32. Yang WP, Levesque PC, Little WA, Conder ML, Shalaby FY, Blanar MA. KvLQT1, a voltage-gated potassium channel responsible for human cardiac arrhythmias. Proc Natl Acad Sci USA. 1997;94:4017-4021.
33. Sugimoto T, Tanabe Y, Shigemoto R, Iwai M, Takumi T, Ohkubo H, et al. Immunohistochemical study of a rat membrane protein which induces a selective potassium permeation: its localization in the apical membrane portion of epithelial cells. J Membr Biol. 1990;113:39-47.
34. Kaczmarek LK, Blumenthal EM. Properties and regulation of the minK potassium channel protein. Physiol Rev. 1997;77:627-641.
35. Kass RS, Moss AJ. Long QT syndrome: novel insights into the mechanisms of cardiac arrhythmias. J Clin Invest. 2003;112: 810-815.
36. Weigt HU, Kwok WM, Rehmert GC, Tumer LA, Bosnjak ZJ. Voltage-dependent effects of volatile anesthetics on cardiac sodium current. Anesth Analg. 1997;84:285-293.
37. + current in rat ventricular myocytes. Br J Pharmacol. 2000;131:223-230.
38. + current in guinea pig ventricular cardiomyocytes. Am J Physiol. 1997;273:H324-H332.
39. Luk HN, Lin CI, Wei J, Chang CL. Depressant effects of isoflurane and halothane on isolated human atrial fibers. Anesthesiology. 1988;69:667-676.
40. Hirota K, Ito Y, Momose Y. Effects of halothane on membrane potentials and membrane ionic currents in single bullfrog atrial cells. Acta Anaesthesiol Scand. 1988;32:333-338.
41. Hatakeyama N, Momose Y, Ito Y. Effects of sevoflurane on contractile responses and electrophysiologic properties in canine single cardiac myocytes. Anesthesiology. 1995;82:559-565.
42. Azuma M, Matsumura C, Kemmotsu O. The effects of sevoflurane on contractile and electrophysiologic properties in isolated guinea pig papillary muscles. Anesth Analg. 1996; 82:486-491.